baber/WOPTO huggingface dataset:
Patent FI-930493-A0 (FI)
Inventor: VAENSKAE MARKO
IPC: G10L19/06
Filed: 1993-02-04
Abstract: PCT No. PCT/EI94/00051 Sec. 371 Date Oct. 4, 1994 Sec. 102(e) Date Oct. 4, 1994 PCT Filed Feb. 3, 1994 PCT Pub. No. WO94/18668 PCT Pub. Date Aug. 18, 1994A method of transmitting and receiving coded speech, in which method samples are taken of a speech signal and reflection coefficients are calculated from these samples. In order to minimize the used transmission rate, characteristics of the reflection coefficients are compared with respective stored sound-specific characteristics of the reflection coefficients for the identification of the sounds, and identifiers of identified sounds are transmitted, speaker-specific characteristics are calculated for the reflection coefficients representing the same sound and stored in a memory, the calculated characteristics of the reflection coefficients representing said sound and stored in the memory are compared with the following characteristics of the reflection coefficients representing the same sound, and if the following characteristics of the reflection coefficients representing the same sound do not essentially differ from the characteristics of the reflection coefficients stored in the memory, differences between the characteristics of the reflection coefficients representing the same sound of the speaker and the characteristics of the reflection coefficients calculated from the previous sample are calculated and transmitted.
Patent FI-935164-A0 (FI)
Inventor: AOBERG BO-CHRISTER
IPC: D21F3/02
Filed: 1993-11-22
Abstract: PCT No. PCT/SE92/00344 Sec. 371 Date Nov. 18, 1993 Sec. 102(e) Date Nov. 18, 1993 PCT Filed May 22, 1992 PCT Pub. No. WO92/20858 PCT Pub. Date Nov. 26, 1992.A press is devised for a papermaking machine. The press is of the type having a rotary press roll, a substantially stationary pressure shoe, and a press belt running in an endless path around the pressure shoe between this and the press roll and having a substantially impermeable inner surface facing the pressure shoe. A separate, endless reinforcing belt enclosing the press belt is in frictional engagement over the entire length of the press belt so as to run together in the press belt in the endless path. The reinforcing belt may be prestressed, e.g. by shrinkage, in its running direction and, optionally, also transversally thereof. According to a second aspect, the invention relates to a method of modifying a press of the type indicated above, in which method the press belt is enclosed by a separate, endless reinforcing belt of the above-indicated type.
Patent FI-941317-A0 (FI)
Inventor: FREDERIKSEN LENE
IPC: B01J13/02
Filed: 1994-03-21
Abstract: The invention relates to an advantageous process for preparing liposomes for inclusion of water-soluble or hydrophilic substances or mixtures of substances, which by comparison with known processes provides the surprising advantage of increasing the content of actually included substances or mixtures of substances and, on pharmaceutical use, the advantage of sterile operating conditions. This entails a mixture consisting of at least one phospholipid and conventional lipophilic auxiliaries being exposed to a mobile support phase consisting of carbon dioxide and a polar organic solvent (modifier) under supercritical pressure and temperature conditions, decompressing the compressed mixed phase to atmospheric pressure, and transferring it into an aqueous phase containing a substance which has water-soluble or hydrophilic properties and is to be encapsulated in liposomes.
Patent FI-961533-A0 (FI)
Inventor: HEBERT MARK P
IPC: H04L69/14
Filed: 1996-04-04
Abstract: A method of operating a programmable telecommunication switch comprising controllable-switching means for dynamically connecting or disconnecting communication paths between various ones of a plurality of ports or channels in response to messages generated by a host device, the method comprising the steps of defining one or more protocols associated with the processing of incoming or outgoing calls, wherein each of the one or more call-associated protocols is represented by a finite state machine and configured to perform even processing, and further wherein different ones of the one or more protocols may be assigned to different ports or channels, detecting the occurrence of an event at one of the plurality of ports or channels, dynamically selecting one of the one or more call associated protocols for processing the occurring event, and performing the selected protocol to process the occurring event.
Patent FI-961544-A0 (FI)
Inventor: BURTON GRAHAM
IPC: A61P35/00
Filed: 1996-04-09
Abstract: beta -Carotene and canthaxanthin, as representative carotenoids, and to a lesser extent, retinoic acid, a representative retinoid, undergo extensive oxidation to yield substances, insofar as oxidized  beta -carotene is a model, which have properties useful as non-toxic agents active against cell proliferation, tumors, and tumorigenic viruses, and useful as promoters of cell differentiation. It is evident from chemical analysis of the highly oxidized  beta -carotene product mixture that none of the various forms of vitamin A are present or are present only in minor amounts. Furthermore, the biological activities of oxidized canthaxanthin and retinoic acid, which cannot form, vitamin A, indicate the presence of active substances that are different from vitamin A. Although the anti-proliferative and differentiation promotion activities of oxidized  beta -carotene resemble those of vitamin A itself, generally the effects are more powerful for oxidized  beta -carotene in a wide variety of circumstances. Unlike vitamin A, the oxidized  beta -carotene of the invention is non-toxic.
Patent FI-962920-A0 (FI)
Inventor: PREIS JOSEF
IPC: H02M3/28
Filed: 1996-07-19
Abstract: The blocking converter has a main power circuit (1) having the primary (21) of a transformer coupled to a supply (11) via an electronic switch (12). The secondary circuit (3) connects with the output (b, c) and has an auxiliary voltage (U4) applied to a regulating circuit (7) that limits the pulsed rate of the electronic switch (2) to an upper threshold value. The secondary circuit connects with a circuit (4) based around diodes (43, 46) and an RC circuit (41, 42) to generate the auxiliary voltage.
Patent FI-964771-A0 (FI)
Inventor: LAUFER STEFAN
IPC: A61P3/06
Filed: 1996-11-29
Abstract: PCT No. PCT/EP95/02077 Sec. 371 Date Mar. 28, 1997 Sec. 102(e) Date Mar. 28, 1997 PCT Filed May 31, 1995 PCT Pub. No. WO95/32970 PCT Pub. Date Dec. 7, 1995The present invention relates to heterocyclic compounds of the formula in which R1-R7, B, a and X have the meanings recited in the specification. These compounds are usable in the treatment of diseases of the rheumatoid variety and for the prevention of allergically induced diseases.
Patent FI-965299-A0 (FI)
Inventor: AHMAVAARA KALLE
IPC: H04W24/04
Filed: 1996-12-31
Abstract: The invention relates to a method for a duplex telecommunication connection in radio connections based on a frame-structured interactive communication and a radio system where the frame-structured interactive communication is performed in the radio connections. The invention provides a means for improving the use of channel resources in the implementation of the interactive telecommunication connection by providing a FDD connection with one or more TDD dimensions. The general approach of the invention is that a full-duplex frequency band is time-duplexed into two or more sub-bands in which interactive communication takes place substantially independently. Transmissions in different transmission directions in each sub-band occur at different times, but a simultaneous transmission can take occur in two different sub-bands in different transmission directions. It is an advantage of the invention in interactive communication that the message is received entirely in one transmission direction before it needs to be responded in another transmission direction in a particular sub-band. On the other hand, the frequency band is utilized effectively for communication because transmission can be performed simultaneously in different sub-bands in the reverse transmission directions.
Patent FI-980736-A0 (FI)
Inventor: AHMAVAARA KALLE
IPC: C07K7/23
Filed: 1998-03-31
Abstract: The invention describes the setting up of a connection of a mobile station in a cellular telecommunication system. When a new connection is opened to the mobile station, the starting time of the interleaving period of said connection is set according to a first predefined rule for aligning the starting times of the interleaving periods of the connections of the mobile station. <IMAGE>
Patent IL-72430-A0 (IL)
Title: 2-(formylamino)-n-(1h-tetrazol-5-yl)-benzamide
IPC: C07D275/06
Filed: 1984-07-18
Abstract: 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and its pharmaceutically acceptable salts are useful as antiallergic agents. The compounds are prepared by the reaction of 2-amino-N-(1H-tetrazol-5-yl)benzamide with formic acetic anhydride.
Patent IL-74086-A0 (IL)
Title: Preparation of o-isopropoxyphenol
IPC: C07C67/00
Filed: 1985-01-17
Abstract: A process for preparing o-isopropoxyphenol (I) by means of the reaction:in which X is a halogen atom and in which the pyrocatechol (II) is reacted with the isopropyl halide (III) in the presence of an alkaline base in the solid state and of a solid-liquid phase transfer catalyst, in a reaction medium constituted by one or more organic solvents.The catalyst is constituted by a quarternary ammonium Of phosphonium salt.The reaction is conducted in a nitrogen atmosphere, at atmospheric pressure, under agitation, at a temperature of preferably between 50°C and 130°C.
Patent IL-84762-A0 (IL)
Title: Pharmaceutically active compounds
IPC: C07D233/60
Filed: 1987-12-09
Abstract: The disclosed invention is compounds represented by the formula <CHEM> and pharmaceutically acceptable acid addition, basic addition and quarternary amine salts thereof and pharmaceutically acceptable solvates thereof, wherein each Z is independently tetiary butyl, phenyl, naphthyl or adamantyl; substituted phenyl, wherein the substituents are one or more of halogen, lower alkoxy, phenoxy, nitrile, nitro, phenyslsulfonyl, loweralkylsulfonyl, oxazol-2-yl, lower alkanoyl, benzoyl, lower alkoxycarbonyl, lower alkyl, lower alkylthio, phenyl, phenylaminothiocarbonyl, or lower alkylaminothiocarbonyl; 4 or 6 membered unsubstituted or substituted heterocyclic ring containing at least one nitrogen with the remaining members of the ring being at least one carbon, and optionally sulfur or oxygen, wherein the substituents are one or more of carboxyl, hydroxymethyl, lower alkyl, loweralkylcarbonyl or aryl lower alkyl;  X and Y are each independently a bond, -O-, <CHEM> each Q is independently a divalent substituted or unsubstituted, straigh or branched chain lower alkanediyl, lower alkanediyl-cycloalkaneidyl-lower alkanediyl, lower alkenediyl, lower alkynediyl, phenylene, dihydrofurandiyl, tetrahydrofurandiyl, tetrahydropyrandiyl, or, loweralkanediyl-tetrahydrofurandiyl-loweralkanediyl, wherein the substituents are one or more of hydroxy, epoxy, fluorine, chlorine, azide, or amino; W is a monovalent substituted or unsubstituted aryl group or a heterocyclic single or fused ring containing from 4 to 10 ring atoms, at least one hetero atom of which is a nitrogen atom and the remaining ring atoms being at least one carbon and optionally sulfur or oxygen, wherein the substituents are one or more of hydroxy, oxo amino, carbamoyl, carboxyl, nitrile, nitro, lower alkoxy carbonyl, halogen, sulfamyl, lower alkyl, lower alkylthio, lower alkoxy, hydroxyloweralkyl, lower alkoxycarbonylloweralkyl, amino loweralkyl, carboxyloweralkyl, guanidino, thioureido, lower alkylsulfonylamino, aminocarbonylloweralkyl, allyloxycarbonylmethyl or carbamoyloxyloweralkyl; with the proviso that W cannot be substituted or unsubstituted isoxazolyl, and  W' is divalent W. The compounds have antiviral activity, antiinflammatory activity and are PAF inhibitors.
Patent IL-89401-A0 (IL)
Title: Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
IPC: C07D211/90
Filed: 1989-02-24
Abstract: Pharmaceuticals containing 1,4-dihydropyridine derivatives can be used as pharmaceuticals for the treatment of alcohol addiction.
Patent IL-97511-A0 (IL)
Title: Urea derivatives,their preparation and medical products containing them
IPC: C07C323/44
Filed: 1991-03-11
Abstract: PCT No. PCT/FR91/00195 Sec. 371 Date Sep. 11, 1992 Sec. 102(e) Date Sep. 11, 1992 PCT Filed Mar. 11, 1991 PCT Pub. No. WO91/13862 PCT Pub. Date Sep. 19, 1991.Compounds of formula:    <IMAGE>  (I)  in which R1 represents an alkyl radical, R2 represents a phenyl radical or a chain -(CH2)m-R4 in which m is equal to 0, 1 or 2 and R, represents a hydroxyl, alkoxy or amino radical, R3 represents a hydrogen atom or an alkyl, alkoxy or alkylthio radical and n is equal to 0 or 1, their preparation and medicinal products containing them.
Patent AU-PM798094-A0 (AU)
Title: A scalpel blade remover
IPC: A61B17/32
Filed: 1994-09-09
Abstract: PCT No. PCT/AU95/00585 Sec. 371 Date Oct. 29, 1996 Sec. 102(e) Date Oct. 29, 1996 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/07363 PCT Pub. Date Mar. 14, 1996A scalpel blade remover removes a blade from the tang of a scalpel. The scalpel is inserted in, and withdrawn from, the blade remover along the same substantially straight-line path. The blade remover has a rocker block which pivots about an axis transverse to the insertion path. When the scalpel is inserted into the blade remover, its tang pushes against a contact surface of the rocker block, causing the rocker block to pivot. A pair of legs at the other end of the rocker block apply a transverse force to the heel of the blade on either side of the tang, thereby lifting the heel of the blade off the tang. When the scalpel has been inserted far enough, a pawl drops behind the heel of the blade. The pawl strips the blade from the tang when the scalpel handle is removed. The blade remover is typically mounted in the lid of a sharps container.
Patent FI-20002493-A0 (FI)
Inventor: BROCKMANN HANS-JUERGEN
IPC: H02J7/02
Filed: 2000-11-14
Abstract: A power supply arrangement comprises a primary side and a secondary side. There is a power transformer between the primary side and the secondary side. On the primary side certain switching means are arranged to repeatedly switch, at a certain frequency, an electric current coupled into the power transformer for cyclically transferring energy from the primary side to the secondary side at said certain frequency. A wireless feedback link exists between the primary side and the secondary side. On the secondary side there are feedback pulse generating means for generating feedback pulses at a certain frequency to be transferred from the secondary side to the primary side over the wireless feedback link. On the primary side there are means for utilizing the feedback pulses in controlling the rate at which energy is transferred from the primary side to the secondary side. The feedback pulse generating means are arranged to generate the feedback pulses at a frequency that is different from the frequency used by the switching means at the primary side to repeatedly switch an electric current coupled into the power transformer. <IMAGE>
Patent FI-20045446-A0 (FI)
Inventor: PATJA TIMO
IPC: A61G7/00
Filed: 2004-11-19
Abstract: The invention relates to an adjustable bed, which comprises a frame (1), a mattress support, a head end member (2) and a foot end member (3). The frame (1) comprises two main parts (6, 7) articulated (8) to each other for turning the frame alternatively to its usage position and its transport and storage position. To easily turn the bed between said positions, the head end member (2) is articulated to the frame (1) through a first linkage system (4), the foot end member is articulated to the frame (1) through a second linkage system (5), and the bed comprises an elongated control means (9, 12) with a first end articulated to the first member (2, 3) and a second end articulated to the main part (6, 7) of the frame that is furthest away from the first member (2, 3), and the control means (9, 12) is arranged to force the first member (2, 3) to turn toward the main part (6, 7) of the frame that is furthest away from the first member as the main parts (6, 7) of the frame turn relative to each other.
Patent FI-20065131-A0 (FI)
Inventor: HOEGLUND GOERAN
IPC: B24B/
Filed: 2006-02-23
Abstract: The present invention relates particularly to an oscillating grinding machine. The grinding machine comprises a driving motor (3) surrounded by a body (3), and a drive shaft (4) cooperating with the driving motor. The drive shaft comprises a grinding head (5) that constitutes a support for a grinding product (8). The drive shaft (4) is arranged in two pieces and comprises a main shaft (11) and an eccentric shaft (10) arranged rigidly thereto. The eccentric shaft comprises a centre line (12) that assumes an angle (±) against a corresponding centre line (13) of the main shaft, and thus the grinding head (5) will assume an eccentric placement in relation to the main shaft (11). Thus, the grinding head is arranged to oscillate in a substantially spherical plane provided by the rotation of the main shaft and the eccentricity and inclination of the eccentric shaft in relation to the main shaft.
Patent FI-20075466-A0 (FI)
IPC: C07K/
Filed: 2007-06-19
Abstract: The present invention relates to a novel transmembrane prostatic acid phosphatase (TM-PAP) protein or the C-terminal part thereof, nucleic acid molecules encoding said protein, vectors containing said nucleic acid molecules and host cells expressing said proteins. The present invention relates also to pharmaceutical compositions containing TM-PAP or the C-terminal part thereof and methods for using thereof in therapy and diagnostics. The present invention also relates to methods utilizing a transmembrane prostatic acid phosphatase knockout/knockdown non-human animal model and uses thereof.
Patent IL-100861-A0 (IL)
Title: N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3,2,1)octanes,intermediates and a process for the preparation thereof and their use as medicaments
IPC: C07D261/20
Filed: 1992-02-03
Abstract: This invention relates to compounds of the formula <CHEM>  where     X is -O-, -S- or -NH-;     Y is hydrogen, halogen and loweralkoxy;     p is 1 or 2;     n is 2, 3 or 4; R is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, amino, loweralkylamino, nitro, loweralkylthio, trifluoromethoxy, cyano, trifluoromethyl, <CHEM>  where aryl is <CHEM> R1 is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, carboxyl, loweralkylamino, nitro, loweralkylthio, cyano, and trifluoromethyl; m is 1 or 2; a pharmaceutically acceptable acid addition salt thereof and, where applicable the geometric and optical isomers and racemic mixtures thereof. The compounds and compositions of this invention are useful as antipsychotic agents and as inhibitors of the reuptake of serotonin.
Patent IL-108185-A0 (IL)
Title: Manufacturing process for panels or similar products made of insulating material and panel or product obtained by such process
IPC: E04B1/78
Filed: 1993-12-27
Abstract: Manufacturing process of panels or finished products, particularly for thermic, sound and similar insulation, by using raw materials like the paper, the Bristol board, the cardboard and similar materials, which are in succession or at deferred times cut to obtain particles with reduced dimensions, mixed to fire-retardant, adhesives, and bonding agents, and additives of various types and compressed at heated or cooled conditions and finally dried and packed. There are described different possibilities of performing the process and different embodiments as well as use modes of the so obtained panels or finished products.
Patent IL-114705-A0 (IL)
Title: Aromatic compounds
IPC: C07C45/68
Filed: 1995-07-24
Abstract: PCT No. PCT/GB95/01728 Sec. 371 Date Jan. 24, 1997 Sec. 102(e) Date Jan. 24, 1997 PCT Filed Jul. 21, 1995 PCT Pub. No. WO96/03380 PCT Pub. Date Feb. 8, 1996The present invention relates to compounds of formula (I),    <IMAGE>  (I)  wherein A is an optionally substituted phenyl naphthyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidyl, thienyl, thiazolyl, oxazolyl, thiadiazolyl having at least two adjacent ring carbon atoms or a bicyclic ring system, provided that the -CH(R3)N(R2)B-R1 and -OCH(R4-)-D linking groups arm positioned in a 1,2 relationship to one another on ring carbon atoms and the ring atom positioned ortho to the -OCHR4- linking group (and therefore in the 3-position relative to the -CHR3NR2- linking group) is not substituted; B is an optionally substituted ring system; D is an optionally substituted ring system; R1 is a variety of group as defined in the description; R2 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, phenylC1-3alkyl or 5- or 6-membered heteroarylC1-3alkyl; R3 is hydrogen or C1-4alkyl; R4 is hydrogen or C1-4alkyl; and N-oxides of NR2 where chemically possible; and S-oxides of sulphur containing rings were chemically possible; and pharmaceutically acceptable salts and in vivo hydrolysable esters and amides thereof. Process for their preparation, intermediates in theirpreparation, their use as therapeutic agents and pharmaceutical compositions containing them.
Patent IL-115514-A0 (IL)
Title: Method for handover multicellular environment
IPC: H04W36/04
Filed: 1995-10-05
Abstract: A method of performing a handover as shown in FIGS. 2-3 for a mobile station in a multicellular environment including the steps of determining to handover from one of the plurality of microcells to the macrocell, performing handover from the one of the plurality of microcells to the macrocell; and sending a false neighbor list to the mobile station.
Patent IL-144847-A0 (IL)
Title: Combinations for the treatment of diseases involving angiogenesis
IPC: A61P19/02
Filed: 2000-02-15
Abstract: Compositions for the inhibition of the formation of new vasculature by angiogenesis are provided comprising the combination of a vasculature damaging agent and an inhibitor of the formation or action of nitric oxide in mammalian systems. There are also provided the use of said combinations in medicaments and kits of said compounds and treatment employing said materials.
Patent IL-146029-A0 (IL)
Title: Device for opening and distributing a bundle of filaments during the production of a nonwoven textile web
IPC: D01D5/098
Filed: 2000-04-20
Abstract: The invention concerns a device for opening and distributing a bundle of filaments when producing a nonwoven textile web by a technique which consists in: extruding melted organic polymer through a die perforated with holes, so as to form a bundle or curtain of filaments; then directing the extruded filaments by drawing by means of one or several fluid jets; and finally, receiving the bundle of filaments in the form of a web on a mobile conveyor belt. The invention is characterised in that it consists of an assembly arranged downstream of the outlet of the drawing assembly and separate therefrom, said assembly comprising, arranged in the proximity of the drawing slot outlet, a diffuser comprising an intake zone shaped as a convergent nozzle extending over the whole width of the installation opposite the drawing slot outlet producing the web, extended by a divergent nozzle, said assembly being associated with a ramp electrostatically charging the filaments before they are received on the receiving belt.
Patent IL-151772-A0 (IL)
Title: Methods for producing pneumococcal capsular polysaccharide
IPC: A61P11/00
Filed: 2001-03-16
Abstract: The invention relates to a method of assessing whether a test compound is useful for alleviating a pneumococcal infection in an animal. This method comprises comparing (a) the degree of phosphorylation of CpsD in pneumococcal cells maintained in the presence of the test compound and (b) the degree of phosphorylation of CpsD in the same type of cells maintained in the absence of the test compound.